BOSTON—The Harvard Business School Kraft Precision Medicine…
https://www.mbcalliance.org/wp-content/uploads/RightTrack2.png496496adminhttps://www.mbcalliance.org/wp-content/uploads/mbca-logo.pngadmin2018-05-14 13:00:582021-11-22 18:23:26Harvard Business School Kraft Precision Medicine Accelerator Brings Together Five Leading Cancer Organizations to Engage Patients and Accelerate Precision Medicine across Cancers
Healthcare organizations are getting outreach tips from big consumer…
https://www.mbcalliance.org/wp-content/uploads/RightTrackMktg.png496496adminhttps://www.mbcalliance.org/wp-content/uploads/mbca-logo.pngadmin2018-02-12 11:27:342021-11-22 15:50:00Cancer organizations get marketing tips from consumer brands to improve patient education
What proportion of MBC patients are de novo vs recurrent?
Currently,…
https://www.mbcalliance.org/wp-content/uploads/CountMe.png8421262Dana Mooneyhttps://www.mbcalliance.org/wp-content/uploads/mbca-logo.pngDana Mooney2017-10-30 20:21:262017-10-30 20:41:13NCI awards Dr. Ruth Etzioni 5-year grant to fill gaps in cancer-recurrence data
Introducing Metastatic Trial Talk plus the re-designed Metastatic Trial Search
NewsHarvard Business School Kraft Precision Medicine Accelerator Brings Together Five Leading Cancer Organizations to Engage Patients and Accelerate Precision Medicine across Cancers
NewsCancer organizations get marketing tips from consumer brands to improve patient education
NewsBEYOND MOONSHOTS AND METASTATIC DISEASE – Expanded Atypical Responders Analysis
NewsNCI awards Dr. Ruth Etzioni 5-year grant to fill gaps in cancer-recurrence data
News